Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis

por Chen, Yu-Tong, Huang, Ze-Ping, Zhou, Zhi-Wei, He, Ming-Ming
Publicado 2016

Latent class analysis-derived classification improves the cancer-specific death stratification of molecular subtyping in colorectal cancer

por Zhou, Wen, He, Ming-Ming, Wang, Feng, Xu, Rui-Hua, Wang, Fang, Zhao, Qi
Publicado 2023

Publisher Correction: Latent class analysis-derived classification improves the cancer-specific death stratification of molecular subtyping in colorectal cancer

por Zhou, Wen, He, Ming-Ming, Wang, Feng, Xu, Rui-Hua, Wang, Fang, Zhao, Qi
Publicado 2023

Immune-Mediated Diseases Associated With Cancer Risks

por He, Ming-ming, Lo, Chun-Han, Wang, Kai, Polychronidis, Georgios, Wang, Liang, Zhong, Rong, Knudsen, Markus D., Fang, Zhe, Song, Mingyang
Publicado 2021

The Role of Non-Curative Surgery in Incurable, Asymptomatic Advanced Gastric Cancer

por He, Ming-ming, Zhang, Dong-sheng, Wang, Feng, Wang, Zhi-qiang, Luo, Hui-yan, Jin, Ying, Wei, Xiao-li, Xu, Rui-hua
Publicado 2013

Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers

por Wu, Hao-Xiang, Chen, Yan-Xing, Wang, Zi-Xian, Zhao, Qi, He, Ming-Ming, Wang, Ying-Nan, Wang, Feng, Xu, Rui-Hua
Publicado 2019

Lymph node staging systems in patients with gastric cancer treated with D2 resection plus adjuvant chemotherapy

por Zhou, Yi-Xin, Yang, Lu-Ping, Wang, Zi-Xian, He, Ming-Ming, Yun, Jing-Ping, Zhang, Dong-Sheng, Wang, Feng, Xu, Rui-Hua
Publicado 2018

The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis

por Wang, Zi-Xian, Yang, Xu-Long, He, Ming-Ming, Wang, Feng, Zhang, Dong-Sheng, Li, Yu-Hong, Zhou, Zhi-Wei, Zhan, You-Qing, Xu, Rui-Hua
Publicado 2016

The clinicopathologic relevance and prognostic value of tumor deposits and the applicability of N1c category in rectal cancer with preoperative radiotherapy

por Wei, Xiao-li, Qiu, Miao-zhen, Zhou, Yi-xin, He, Ming-ming, Luo, Hui-yan, Wang, Feng-hua, Zhang, Dong-sheng, Li, Yu-hong, Xu, Rui-hua
Publicado 2016

The survival benefit of palliative gastrectomy and/or metastasectomy in gastric cancer patients with synchronous metastasis: a population-based study using propensity score matchin...

por Yang, Lu-Ping, Wang, Zi-Xian, He, Ming-Ming, Jin, Ying, Ren, Chao, Wang, Zhi-Qiang, Wang, Feng-Hua, Li, Yu-Hong, Wang, Feng, Xu, Rui-Hua
Publicado 2019

Comprehensive genomic characterization of sporadic synchronous colorectal cancer: Implications for treatment optimization and clinical outcome

por Yang, Lu-Ping, Jiang, Teng-Jia, He, Ming-Ming, Ling, Yi-Hong, Wang, Zi-Xian, Wu, Hao-Xiang, Zhang, Zhen, Xu, Rui-Hua, Wang, Feng, Yuan, Shu-Qiang, Zhao, Qi
Publicado 2023

S-1-Based Chemotherapy versus Capecitabine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Carcinoma: A Meta-Analysis

por He, Ming-ming, Wu, Wen-jing, Wang, Feng, Wang, Zhi-qiang, Zhang, Dong-sheng, Luo, Hui-yan, Qiu, Miao-zhen, Wang, Feng-hua, Ren, Chao, Zeng, Zhao-lei, Xu, Rui-hua
Publicado 2013

microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer

por Chen, Dong-liang, Zhang, Dong-sheng, Lu, Yun-xin, Chen, Le-zong, Zeng, Zhao-lei, He, Ming-ming, Wang, Feng-hua, Li, Yu-hong, Zhang, Hui-zhong, Pelicano, Helene, Zhang, Wei, Xu, Rui-hua
Publicado 2015

Correlation of Milestone Restricted Mean Survival Time Ratio With Overall Survival Hazard Ratio in Randomized Clinical Trials of Immune Checkpoint Inhibitors: A Systematic Review a...

por Wang, Zi-Xian, Wu, Hao-Xiang, Xie, Li, Wang, Ying-Nan, Yang, Lu-Ping, He, Ming-Ming, Luo, Hui-Yan, Ding, Pei-Rong, Xie, Dan, Chen, Gong, Li, Yu-Hong, Wang, Feng, Xu, Rui-Hua
Publicado 2019

A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients

por Yang, Lu-Ping, Wang, Zi-Xian, He, Ming-Ming, Wu, Hao-Xiang, Yuan, Shu-Qiang, Wang, Wei, Jin, Ying, Ren, Chao, Wang, Zhi-Qiang, Wang, Feng-Hua, Li, Yu-Hong, Wang, Feng, Xu, Rui-Hua
Publicado 2019

LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription

por Luo, Xiao-Jing, He, Ming-Ming, Liu, Jia, Zheng, Jia-Bo, Wu, Qi-Nian, Chen, Yan-Xing, Meng, Qi, Luo, Kong-Jia, Chen, Dong-Liang, Xu, Rui-Hua, Zeng, Zhao-Lei, Liu, Ze-Xian, Luo, Hui-Yan
Publicado 2022

A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio

por Wei, Xiao-li, Wang, Feng-hua, Zhang, Dong-sheng, Qiu, Miao-zhen, Ren, Chao, Jin, Ying, Zhou, Yi-xin, Wang, De-shen, He, Ming-ming, Bai, Long, Wang, Feng, Luo, Hui-yan, Li, Yu-hong, Xu, Rui-hua
Publicado 2015

Phase II clinical trial of S‐1 plus nanoparticle albumin‐bound paclitaxel in untreated patients with metastatic gastric cancer

por He, Ming‐ming, Wang, Feng, Jin, Ying, Yuan, Shu‐qiang, Ren, Chao, Luo, Hui‐yan, Wang, Zhi‐qiang, Qiu, Miao‐zhen, Wang, Zi‐xian, Zeng, Zhao‐lei, Li, Yu‐hong, Wang, Feng‐hua, Zhang, Dong‐sheng, Xu, Rui‐hua
Publicado 2018

Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis

por Wang, Feng, He, Ming-Ming, Yao, Yi-Chen, Zhao, Xia, Wang, Zhi-Qiang, Jin, Ying, Luo, Hui-Yan, Li, Ji-Bin, Wang, Feng-Hua, Qiu, Miao-Zhen, Lv, Zhi-Da, Wang, De-Shen, Li, Yu-Hong, Zhang, Dong-Sheng, Xu, Rui-Hua
Publicado 2021

Right- and left-sided colorectal cancers respond differently to cetuximab

por Wang, Feng, Bai, Long, Liu, Tian-Shu, Yu, Yi-Yi, He, Ming-Ming, Liu, Kai-Yan, Luo, Hui-Yan, Zhang, Dong-Sheng, Jin, Yin, Wang, Feng-Hua, Wang, Zhi-Qiang, Wang, De-Shen, Qiu, Miao-Zhen, Ren, Chao, Li, Yu-Hong, Xu, Rui-Hua
Publicado 2015